Dolutegravir

298+ PubMed studies analyzed · BiohacksAI corpus v20260307-01

PubMed Studies

298+

Targets

Pathways

Molecular Targets

TMEM97 SLC22A2 SIGMAR1 SLC18A3

Molecular targets identified in BiohacksAI corpus. Click to explore all compounds affecting each target.

Biological Pathways

GLUCOSE_METABOLISM INFLAMMATION INSULIN_SIGNALING OXIDATIVE_STRESS CALCIUM_SIGNALING NAD_METABOLISM LIPID_METABOLISM DOPAMINE_SEROTONIN IMMUNE_FUNCTION AUTOPHAGY

Biological pathways associated with Dolutegravir based on target analysis.

Biological Mechanisms

NF-κBNF-κB IRSInsulin Signaling NRF2Nrf2 NGFNeuroplasticity NAD⁺NAD⁺ Metabolism NLRP3NLRP3 Inflammasome ATGAutophagy

Biological mechanisms activated or modulated by Dolutegravir based on pathway and target analysis.

Health Goals

Inflammation →Longevity →Energy →Neuroprotection →Memory →

Health goals where Dolutegravir ranks among evidence-based compounds in the BiohacksAI corpus.

Related Conditions

Chronic Inflammation →Arthritis →Type 2 Diabetes →Metabolic Syndrome →Alzheimer's →

Health conditions associated with the biological pathways influenced by Dolutegravir.

External References

PubChem CID 54726191 →298 PubMed studies →

Similar Compounds

Explore compounds with similar target profiles and pathway overlap.

Data Source

Corpusv20260307-01

PubMed studies298

PubChem CID54726191

SourcePubMed / NCBI · ChEMBL · Reactome · PubChem

All data is computationally derived from published research. Molecular structure images from PubChem (public domain). Not medical advice. Independent validation required.

This compound profile for Dolutegravir is generated from 298 PubMed-indexed studies. Key molecular targets include TMEM97, SLC22A2, SIGMAR1. Associated biological pathways: GLUCOSE_METABOLISM, INFLAMMATION, INSULIN_SIGNALING. BiohacksAI does not provide medical advice. Consult a healthcare professional before starting any supplement regimen.